Andreas Arnell

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
In drug development, the "onus" of the low R&D efficiency has been put traditionally onto the drug discovery process (i.e., finding the right target or "binding" functionality). Here, we show that manufacturing is not only a central component of product success, but also that, by integrating manufacturing and discovery activities in a "holistic"(More)
  • 1